NovoRapid FlexPen

NovoRapid FlexPen is a fast-acting insulin aspart used to control high blood sugar in adults and children with diabetes mellitus. This life-saving medication is designed as a pre-filled, disposable injection pen intended for subcutaneous use.

Developed by the Danish pharmaceutical giant Novo Nordisk, the product remains one of the leading global brands in diabetes care. Novo Nordisk, headquartered in Bagsværd, Denmark, is a global healthcare company with nearly a century of innovation in diabetes and other serious chronic diseases. While the primary research and original manufacturing were established in Denmark, the company utilizes a global supply chain with significant production facilities across Europe and South America to meet international demand.